-
1دورية أكاديمية
المؤلفون: Gulati A; Maxillofacial Unit, Queen Alexandra Hospital, Portsmouth PO6 3LY, UK., Herd MK, Nimako M, Anand R, Brennan PA
المصدر: The British journal of oral & maxillofacial surgery [Br J Oral Maxillofac Surg] 2012 Jul; Vol. 50 (5), pp. 385-8. Date of Electronic Publication: 2011 Jul 23.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 8405235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1940 (Electronic) Linking ISSN: 02664356 NLM ISO Abbreviation: Br J Oral Maxillofac Surg Subsets: MEDLINE
مواضيع طبية MeSH: Compensation and Redress/*legislation & jurisprudence , Diagnostic Errors/*legislation & jurisprudence , Insurance Claim Review/*legislation & jurisprudence , Malpractice/*legislation & jurisprudence , National Health Programs/*legislation & jurisprudence , Oral Surgical Procedures/*legislation & jurisprudence, Diagnostic Errors/economics ; Humans ; Insurance Claim Review/economics ; Malpractice/economics ; Malpractice/trends ; National Health Programs/economics ; Oral Surgical Procedures/statistics & numerical data ; United Kingdom
-
2دورية أكاديمية
المؤلفون: Nimako M; Department of Medicine, University of Wales College of Medicine, Cardiff, United Kingdom., Fiander AN, Wilkinson GW, Borysiewicz LK, Man S
المصدر: Cancer research [Cancer Res] 1997 Nov 01; Vol. 57 (21), pp. 4855-61.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Print ISSN: 0008-5472 (Print) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: DNA-Binding Proteins* , Repressor Proteins*, Carcinoma in Situ/*virology , Monocytes/*immunology , Oncogene Proteins, Viral/*immunology , Papillomaviridae/*immunology , T-Lymphocytes, Cytotoxic/*immunology , Uterine Cervical Neoplasms/*virology, Adult ; Carcinoma in Situ/blood ; Carcinoma in Situ/immunology ; Female ; Humans ; Immunity, Cellular ; Middle Aged ; Papillomavirus E7 Proteins ; Phenotype ; Uterine Cervical Neoplasms/blood ; Uterine Cervical Neoplasms/immunology
-
3دورية أكاديمية
المؤلفون: Borysiewicz LK; Department of Medicine, University of Wales College of Medicine, Cardiff, UK., Fiander A, Nimako M, Man S, Wilkinson GW, Westmoreland D, Evans AS, Adams M, Stacey SN, Boursnell ME, Rutherford E, Hickling JK, Inglis SC
المصدر: Lancet (London, England) [Lancet] 1996 Jun 01; Vol. 347 (9014), pp. 1523-7.
نوع المنشور: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print ISSN: 0140-6736 (Print) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
مواضيع طبية MeSH: Oncogene Proteins, Viral*/*therapeutic use, DNA-Binding Proteins* , Immunotherapy, Active* , Papillomaviridae* , Repressor Proteins* , Vaccinia virus*, Uterine Cervical Neoplasms/*therapy , Vaccines, Synthetic/*therapeutic use, Adult ; Aged ; Antibodies, Viral/immunology ; Female ; Humans ; Middle Aged ; Papillomavirus E7 Proteins ; Papillomavirus Vaccines ; T-Lymphocytes, Cytotoxic/immunology ; Uterine Cervical Neoplasms/immunology ; Uterine Cervical Neoplasms/virology ; Viral Vaccines